Should a Company Repeat a Study When Results Are Not as Expected?

Clinical study results should be interpreted and reported accurately, including neutral or unfavorable findings, limitations, uncertainty, adverse events, and protocol deviations, without selective reporting or misrepresentation.

Unexpected, neutral, or unfavorable findings should be investigated objectively rather than hidden or selectively reframed. Decisions about repeat studies should be scientifically justified, not driven solely by a desire to obtain a favorable result.

Unexpected, neutral, or unfavorable findings should be investigated objectively rather than hidden or selectively reframed
Unexpected, neutral, or unfavorable findings should be investigated objectively rather than hidden or selectively reframed

Clinical Research


Study reports should present methods, participant disposition, analyses, results, adverse events, protocol deviations, limitations, and conclusions accurately. Publication and communication should avoid selective reporting, unsupported causal claims, or omission of material limitations.

Study reports should present methods, participant disposition, analyses, results, adverse events, protocol deviations, limitations, and conclusions accurately. Publication and communication should avoid selective reporting, unsupported causal claims, or omission of material limitations.

Study reports should present methods, participant disposition, analyses, results, adverse events, protocol deviations, limitations, and conclusions accurately
Study reports should present methods, participant disposition, analyses, results, adverse events, protocol deviations, limitations, and conclusions accurately

Clinical Research


Unexpected, neutral, or unfavorable findings should be investigated objectively rather than hidden or selectively reframed. Decisions about repeat studies should be scientifically justified, not driven solely by a desire to obtain a favorable result.

1. Clinical Research

Study reports should present methods, participant disposition, analyses, results, adverse events, protocol deviations, limitations, and conclusions accurately. Publication and communication should avoid selective reporting, unsupported causal claims, or omission of material limitations.

2. Clinical Research

Unexpected, neutral, or unfavorable findings should be investigated objectively rather than hidden or selectively reframed. Decisions about repeat studies should be scientifically justified, not driven solely by a desire to obtain a favorable result.

3. Clinical Research

Study reports should present methods, participant disposition, analyses, results, adverse events, protocol deviations, limitations, and conclusions accurately. Publication and communication should avoid selective reporting, unsupported causal claims, or omission of material limitations.

4. Costs

Study reports should present methods, participant disposition, analyses, results, adverse events, protocol deviations, limitations, and conclusions accurately. Publication and communication should avoid selective reporting, unsupported causal claims, or omission of material limitations.

5. Clinical Research

Study reports should present methods, participant disposition, analyses, results, adverse events, protocol deviations, limitations, and conclusions accurately. Publication and communication should avoid selective reporting, unsupported causal claims, or omission of material limitations.

Unexpected, neutral, or unfavorable findings should be investigated objectively rather than hidden or selectively reframed
Unexpected, neutral, or unfavorable findings should be investigated objectively rather than hidden or selectively reframed

Clinical Research


Study reports should present methods, participant disposition, analyses, results, adverse events, protocol deviations, limitations, and conclusions accurately. Publication and communication should avoid selective reporting, unsupported causal claims, or omission of material limitations.

1. Clinical Research

Study reports should present methods, participant disposition, analyses, results, adverse events, protocol deviations, limitations, and conclusions accurately. Publication and communication should avoid selective reporting, unsupported causal claims, or omission of material limitations.

2. Clinical Research

Unexpected, neutral, or unfavorable findings should be investigated objectively rather than hidden or selectively reframed. Decisions about repeat studies should be scientifically justified, not driven solely by a desire to obtain a favorable result.

3. Clinical Research

Unexpected, neutral, or unfavorable findings should be investigated objectively rather than hidden or selectively reframed. Decisions about repeat studies should be scientifically justified, not driven solely by a desire to obtain a favorable result.

4. Clinical Research

Study reports should present methods, participant disposition, analyses, results, adverse events, protocol deviations, limitations, and conclusions accurately. Publication and communication should avoid selective reporting, unsupported causal claims, or omission of material limitations.

Study reports should present methods, participant disposition, analyses, results, adverse events, protocol deviations, limitations, and conclusions accurately
Study reports should present methods, participant disposition, analyses, results, adverse events, protocol deviations, limitations, and conclusions accurately

Clinical Research


Study reports should present methods, participant disposition, analyses, results, adverse events, protocol deviations, limitations, and conclusions accurately. Publication and communication should avoid selective reporting, unsupported causal claims, or omission of material limitations.

1. Clinical Research

Study reports should present methods, participant disposition, analyses, results, adverse events, protocol deviations, limitations, and conclusions accurately. Publication and communication should avoid selective reporting, unsupported causal claims, or omission of material limitations.

2. Data Management

Study reports should present methods, participant disposition, analyses, results, adverse events, protocol deviations, limitations, and conclusions accurately. Publication and communication should avoid selective reporting, unsupported causal claims, or omission of material limitations.

3. Clinical Research

Study reports should present methods, participant disposition, analyses, results, adverse events, protocol deviations, limitations, and conclusions accurately. Publication and communication should avoid selective reporting, unsupported causal claims, or omission of material limitations.

4. Clinical Research

Unexpected, neutral, or unfavorable findings should be investigated objectively rather than hidden or selectively reframed. Decisions about repeat studies should be scientifically justified, not driven solely by a desire to obtain a favorable result.

Study reports should present methods, participant disposition, analyses, results, adverse events, protocol deviations, limitations, and conclusions accurately
Study reports should present methods, participant disposition, analyses, results, adverse events, protocol deviations, limitations, and conclusions accurately

Conclusion


The Academy of Medical Sciences, Vietnam approaches clinical research through scientifically justified protocols, independent ethics oversight, participant protection, appropriate operations, data-quality controls, statistical analysis, and transparent reporting.

The Academy of Medical Sciences, Vietnam approaches clinical research through scientifically justified protocols, independent ethics oversight, participant protection, appropriate operations, data-quality controls, statistical analysis, and transparent reporting
The Academy of Medical Sciences, Vietnam approaches clinical research through scientifically justified protocols, independent ethics oversight, participant protection, appropriate operations, data-quality controls, statistical analysis, and transparent reporting
Quick Contact